Skip to main content
. 2020 Jul 17;9(7):2276. doi: 10.3390/jcm9072276

Figure 3.

Figure 3

HbF and cytotoxicity profile of overlapping screen hits on K562 and HEL92.1.7 cell lines. (A) Immunoblot validations of screen candidates in K562 and HEL92.1.7 cell lines normalized to DMSO; (B) MTS viability assays of screen candidates in K562 and HEL92.1.7 normalized to DMSO.